NCT04751019 is a NA clinical trial of Amber Glasses in Sleep Disturbance, sponsored by Surrey and Borders Partnership NHS Foundation Trust.

Who is sponsoring NCT04751019?

NCT04751019 is sponsored by Surrey and Borders Partnership NHS Foundation Trust.

What drugs are being tested in NCT04751019?

Interventions in NCT04751019: Amber Glasses.

What condition does NCT04751019 study?

NCT04751019 studies Sleep Disturbance, Insomnia.

Is NCT04751019 still recruiting?

NCT04751019 is currently completed. Last updated 11 February 2021.

Last reviewed 2021-02-11 · How we verify

NCT04751019

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Amber Glasses in Improving Sleep

Completed NA Last updated 11 February 2021

What this trial tests

NA trial testing Amber Glasses in Sleep Disturbance in 15 participants. Completed in 31 January 2020.

Timeline

11 March 2019

Primary endpoint
31 January 2020

31 January 2020

Quick facts

Lead sponsor	Surrey and Borders Partnership NHS Foundation Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	11 March 2019
Primary completion	31 January 2020
Estimated completion	31 January 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Amber Glasses

Conditions studied

Sleep Disturbance — all drugs for Sleep Disturbance →
Insomnia — all drugs for Insomnia →

Sponsor

Surrey and Borders Partnership NHS Foundation Trust

Who can join

18 and older, any sex, with Sleep Disturbance or Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of amber glasses will aid the patient to fall asleep without the need for the use of hypnotic medication.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Amber Glasses

Trials testing the same drug.

NCT04378933 — Glasses for Adolescent Delayed Sleep-Wake Phase Disorder · NA · completed

Other recruiting trials for Sleep Disturbance

Currently open trials in the same condition.

NCT07503223 — Sleep Optimization With Acoustic Therapy · NA · recruiting
NCT07464626 — Virtual vs Physical Art Therapy for Anxiety, Psychological Well-being, and Sleep Quality in Colorectal Cancer Patients · NA · recruiting
NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
NCT07354776 — Effect of Isometric Neck Exercises on Cervicogenic Headache, Cortisol, and BDNF in Adolescents With Smartphone Addiction · NA · recruiting
NCT07119268 — SPARK Healthy Sleep · NA · recruiting

Other Surrey and Borders Partnership NHS Foundation Trust trials

Trials by the same sponsor.

NCT05838859 — Contraception and Mental Health: Are we Doing Enough? · unknown
NCT04797533 — Minebea: Inpatient Monitoring Activity Project (IMAP) (Pilot) · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04751019 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Surrey and Borders Partnership NHS Foundation Trust
Last refreshed: 11 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04751019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing